Buy or sell Synthace stock pre IPO via an EquityZen fund
Synthace is a Life Sciences R&D cloud platform that enables experiments to be automated, with the resultant data seamlessly integrated.
About Synthace Stock
Synthace is a R&D cloud platform. Synthace aims to automate experimentation and insight sharing for scientists to share, view, and access progress with cures and therapeutics in one place.
Synthace was founded in 2011 and is headquartered in London, White City. Notable investors include Horizons Ventures, Sofinnova Partners, Amadeus Capital Partners, and Luminous Ventures.
Co-founder & Chief Scientific Officer
Chief Product Officer
prnewswire - Dec, 7 2021
businesscloud - Nov, 17 2021
finsmes - Nov, 16 2021
ow - May, 20 2021
zpr - Mar, 9 2021
uktech - Nov, 5 2020
sofinnovapartners - Jun, 11 2020